Retroprosthetic membranes in AlphaCor patients - Risk factors and prevention

被引:46
作者
Hicks, CR
Hamilton, S
机构
[1] Univ Western Australia, Lions Eye Inst, Biomat Res Ctr, Perth, WA 6009, Australia
[2] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia
[3] Piedmont Hosp, Eye Consultants Atlanta, Atlanta, GA USA
关键词
AlphaCor artificial cornea; biointegration; histology; retroprosthetic membrane; risk factors; prevention;
D O I
10.1097/01.ico.0000154380.13237.ea
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To report retroprosthetic membrane (RPM) formation in association with AlphaCor and identify risk factors for their formation and strategies for prevention and management. Methods: Review of AlphaCor data and case histories and literature review. Results: RPMs occurred with AlphaCor in 14 (9.3%) cases. We find significant associations with systemic risk factors (race, hypertension, diabetes mellitus) rather than ocular history, but perioperative management may also be related to risk of RPM development. Histology demonstrates a fibrovascular tissue resembling scarred corneal tissue. Similar histologic findings have been reported for other devices. Conclusion: Retrocorneal membranes and RPMs with earlier keratoprostheses have frequently been reported without specific identifiable causes. Diabetes is known to be associated with intraocular membrane formation. This study demonstrates that systemic factors affect the risk of RPM formation with AlphaCor. In cases identified as at greater risk of membrane formation, peri- and postoperative therapies such as steroids, non-steroidals, heparin or rTPA should be considered. In our series, several therapeutic and surgical strategies appear effective but recognizing patients at increased risk preoperatively and using preventive measures where indicated is likely to be key to minimizing the incidence of this complication.
引用
收藏
页码:692 / 698
页数:7
相关论文
共 43 条
[1]
AQUAVELLA JV, 1982, OPHTHALMOLOGY, V89, P655
[2]
Azuara-Blanco A, 1998, BRIT J OPHTHALMOL, V82, P1345
[3]
BATH PE, 1984, AM INTRAOCULAR IMPLA, V11, P253
[4]
Characterization of fibrous retrocorneal membrane by confocal microscopy [J].
Chiou, AGY ;
Chang, C ;
Kaufman, SC ;
Ohta, T ;
Maitchouk, D ;
Beuerman, RW ;
Kaufman, HE .
CORNEA, 1998, 17 (06) :669-671
[5]
INTERPENETRATING POLYMER NETWORK (IPN) AS A PERMANENT JOINT BETWEEN THE ELEMENTS OF A NEW-TYPE OF ARTIFICIAL CORNEA [J].
CHIRILA, TV ;
VIJAYASEKARAN, S ;
HORNE, R ;
CHEN, YC ;
DALTON, PD ;
CONSTABLE, IJ ;
CRAWFORD, GJ .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (06) :745-753
[6]
The Chirila Keratoprosthesis: Phase I human clinical trial [J].
Crawford, GJ ;
Hicks, CR ;
Lou, X ;
Vijayasekaran, S ;
Tan, D ;
Mulholland, B ;
Chirila, TV ;
Constable, IJ .
OPHTHALMOLOGY, 2002, 109 (05) :883-889
[7]
Histopathology of explanted collar button keratoprostheses: A clinicopathologic correlation [J].
Dudenhoefer, EJ ;
Nouri, M ;
Gipson, IK ;
Baratz, KH ;
Tisdale, AS ;
Dryja, TP ;
Abad, JC ;
Dohlman, CH .
CORNEA, 2003, 22 (05) :424-428
[8]
Control of intra-ocular inflammation associated with cataract surgery [J].
El-Harazi, Sherif M. ;
Feldman, Robert M. .
CURRENT OPINION IN OPHTHALMOLOGY, 2001, 12 (01) :4-8
[9]
Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [J].
Heier, J ;
Cheetham, JK ;
Degryse, R ;
Dirks, MS ;
Caldwell, DR ;
Silverstone, DE ;
Rosenthal, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 127 (03) :253-259
[10]
Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study [J].
Heiligenhaus, A ;
Steinmetz, B ;
Lapuente, R ;
Krallmann, P ;
Althaus, C ;
Steinkamp, WK ;
Dick, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (07) :810-815